Reciprocal interferences of the left ventricular assist device and the aortic valve competence

被引:5
作者
Vriz, Olga [1 ]
Mushtaq, Ali [2 ]
Shaik, Abdullah [2 ]
El-Shaer, Ahmed [2 ]
Feras, Khalid [1 ]
Eltayeb, Abdalla [1 ]
Alsergnai, Hani [1 ]
Kholaif, Naji [1 ]
Al Hussein, Mosaad [1 ]
Albert-Brotons, Dimpna [1 ]
Simon, Andre Rudiger [1 ]
Tsai, Felix Wang [1 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Heart Ctr Dept, Riyadh, Saudi Arabia
[2] Alfaisal Univ, Sch Med, Riyadh, Saudi Arabia
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2023年 / 9卷
关键词
heart transplant; left ventricular assist device (LVAD); aortic regurgitation; transcatheter aortic valve implantation (TAVI); surgical intervention; END-STAGE HEART; CONTINUOUS-FLOW; PULSATILE-FLOW; INTERNATIONAL SOCIETY; INTERMACS ANALYSIS; AMERICAN SOCIETY; BLOOD-FLOW; INSUFFICIENCY; SUPPORT; FAILURE;
D O I
10.3389/fcvm.2022.1094796
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients suffering from end-stage heart failure tend to have high mortality rates. With growing numbers of patients progressing into severe heart failure, the shortage of available donors is a growing concern, with less than 10% of patients undergoing cardiac transplantation (CTx). Fortunately, the use of left ventricular assist devices (LVADs), a variant of mechanical circulatory support has been on the rise in recent years. The expansion of LVADs has led them to be incorporated into a variety of clinical settings, based on the goals of therapy for patients ailing from heart failure. However, with an increase in the use of LVADs, there are a host of complications that arise with it. One such complication is the development and progression of aortic regurgitation (AR) which is noted to adversely influence patient outcomes and compromise pump benefits leading to increased morbidity and mortality. The underlying mechanisms are likely multifactorial and involve the aortic root-aortic valve (AV) complex, as well as the LVAD device, patient, and other factors, all of them alter the physiological mechanics of the heart resulting in AV dysfunction. Thus, it is imperative to screen patients before LVAD implantation for AR, as moderate or greater AR requires a concurrent intervention at the time of LVADs implantation. No current strict guidelines were identified in the literature search on how to actively manage and limit the development and/or progression of AR, due to the limited information. However, some recommendations include medical management by targeting fluid overload and arterial blood pressure, along with adjusting the settings of the LVADs device itself. Surgical interventions are to be considered depending on patient factors, goals of care, and the underlying pathology. These interventions include the closure of the AV, replacement of the valve, and percutaneous approach via percutaneous occluding device or transcatheter aortic valve implantation. In the present review, we describe the interaction between AV and LVAD placement, in terms of patient management and prognosis. Also it is provided a comprehensive echocardiographic strategy for the precise assessment of AV regurgitation severity.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Concomitant Transcatheter Aortic Valve and Left Ventricular Assist Device Implantation
    Baum, Christina
    Seiffert, Moritz
    Treede, Hendrik
    Reichenspurner, Hermann
    Deuse, Tobias
    ASAIO JOURNAL, 2013, 59 (01) : 90 - 92
  • [2] Aortic valve pathophysiology during left ventricular assist device support
    John, Ranjit
    Mantz, Katie
    Eckman, Peter
    Rose, Alan
    May-Newman, Karen
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (12) : 1321 - 1329
  • [3] Aortic valve disorders and left ventricular assist devices
    Acharya, Deepak
    Kazui, Toshinobu
    Al Rameni, Dina
    Acharya, Tushar
    Betterton, Edward
    Juneman, Elizabeth
    Loyaga-Rendon, Renzo
    Lotun, Kapildeo
    Shetty, Ranjith
    Chatterjee, Arka
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [4] Aortic regurgitation in left ventricular assist device patients - Does aortic root dilatation contribute to valve incompetence?
    Faerber, Gloria
    Schneider, Ulrich
    Graeger, Stephanie
    Elayan, Yousef
    Schwan, Imke
    Tkebuchava, Sophie
    Kirov, Hristo
    Caldonazo, Tulio
    Diab, Mahmoud
    Doenst, Torsten
    ARTIFICIAL ORGANS, 2024, : 292 - 299
  • [5] Transcatheter Aortic Valve Replacement for Severe Aortic Regurgitation in Patients With a Left Ventricular Assist Device
    Dhillon, Ashwat S.
    Jones, Brandon M.
    Hodson, Robert W.
    Korngold, Ethan C.
    JOURNAL OF INVASIVE CARDIOLOGY, 2022, 34 (05) : E369 - E373
  • [6] Transcatheter aortic valve implantation for left ventricular assist device-related aortic regurgitation
    Tomii, Daijiro
    Reineke, David
    Hunziker, Lukas
    Pilgrim, Thomas
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2024, 65 (03)
  • [7] Potential benefits of aortic valve opening in patients with left ventricular assist devices
    Dorta, Elena Romero
    Meyn, Robert
    Mueller, Markus
    Hoermandinger, Christoph
    Schoenrath, Felix
    Falk, Volkmar
    Meyer, Alexander
    Merke, Nicolas
    Potapov, Evgenij
    Mulzer, Johanna
    Knierim, Jan
    ARTIFICIAL ORGANS, 2024, : 441 - 450
  • [8] Left ventricular assist device implantation and concomitant aortic valve replacement
    Mikic, Aleksandar
    Nestorovic, Emilija
    Bilbija, Ilija
    Terzic, Dusko
    Putnik, Svetozar
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2019, 147 (11-12) : 758 - 761
  • [9] Transcatheter aortic valve implantation in patients with a left ventricular assist device: a word of caution
    Ali, Jason
    Catarino, Pedro
    Abu-Omar, Yasir
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2020, 58 (06) : 1309 - 1310
  • [10] Secondary aortic valve replacement in continuous flow left ventricular assist device therapy
    Gyoten, Takayuki
    Morshuis, Michiel
    Fox, Henrik
    Deutsch, Marcus-Andre
    Hakim-Meibodi, Kavous
    Schramm, Rene
    Gummert, Jan F.
    Rojas, Sebastian V.
    ARTIFICIAL ORGANS, 2021, 45 (07) : 736 - 741